The finding of absent expression of claudin 4 in apocrine carcinoma, with its known good prognosis, is also consistent with the reported association between claudin 4 over-expression and poor prognosis and increased incidence of axillary and distant metastasis in breast carcinoma [8, 9, 19]. The gene discussed is CLDN4; the disease is breast carcinoma.